MicroRNA-151a emerges as a promising diagnostic biomarker for AD, while also playing a crucial role in regulating the IL-12 receptor β2 (IL12RB2), shedding light on potential therapeutic avenues [20]. Here, IL12RB2 is linked to Alzheimer disease.